Lorena Lerner

1.5k citations

23 papers · 1.2k indexed · h-index 13

Impact in

Rheumatology top 5%
- GDF15 and Related Biomarkers
Physiology top 10%
- Nutrition and Health in Aging

Papers in ⓘ

Molecular Biology 8
- RNA Interference and Gene Delivery 3
- Kruppel-like factors research 2
Rheumatology 7
- GDF15 and Related Biomarkers 7

Co-authors: Jenő Gyuris (10 shared papers)M. Isabel Chiu (4 shared papers)Richard Nicoletti (5 shared papers)Brian Krieger (5 shared papers)Nianjun Tao (4 shared papers)H. Werchau (1 shared paper)H. Hilpert (1 shared paper)C Mietens (1 shared paper)
Journals: Cancer Research (5 papers)Molecular Therapy — Oncolytics (2 papers)Journal of Cachexia Sarcopenia and Muscle (2 papers)Molecular Cancer Therapeutics (1 paper)Immunology (1 paper)
Partner nations: United States Norway Switzerland

In The Last Decade

Lorena Lerner

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by Lorena Lerner

Since Specialization

Citations

This map shows the geographic impact of Lorena Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Lerner more than expected).

Fields of papers citing papers by Lorena Lerner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Lerner. The network helps show where Lorena Lerner may publish in the future.

Co-authors

The 25 scholars most cited alongside Lorena Lerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lorena Lerner Line = papers co-authored together Lorena Lerner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer Molecular Cancer Therapeutics ·Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak, Eric Brown, Alexandra Eyzaguirre, Nianjun Tao, Maryland Rosenfeld-Franklin, Lorena Lerner, M. Isabel Chiu, Robert Wild, David Epstein, Jonathan A. Pachter, Mark Miglarese	2010	183
2	Use of Bovine Milk Concentrate Containing Antibody to Rotavirus to Treat Rotavirus Gastroenteritis in Infants The Journal of Infectious Diseases ·H. Hilpert, H. Briissow, C Mietens, J Sidoti, Lorena Lerner, H. Werchau	1987	165
3	Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients Journal of Cachexia Sarcopenia and Muscle ·Lorena Lerner, Teresa G. Hayes, Nianjun Tao, Brian Krieger, Bin Feng, Zhenhua Wu, Richard Nicoletti, M. Isabel Chiu, Jenő Gyuris, José M. Garcia	2015	152
4	MAP3K11/GDF15 axis is a critical driver of cancer cachexia Journal of Cachexia Sarcopenia and Muscle ·Lorena Lerner, Julie Tao, Qing Liu, Richard Nicoletti, Bin Feng, Brian Krieger, Elizabeth K. Mazsa, Zakir Siddiquee, Ruoji Wang, Lucia Huang, Luhua Shen, Jie Lin, Antonio Viganò, M. Isabel Chiu, Zhigang Weng, William M. Winston, Solly Weiler, Jenő Gyuris	2015	146
5	GP369, an FGFR2-IIIb–Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 Signaling Cancer Research ·Ailin Bai, Kristan Meetze, Nhi Vo, Sriram Kollipara, Elizabeth K. Mazsa, William M. Winston, Solly Weiler, Laura L. Poling, Ting Chen, Nesreen S. Ismail, Jinwei Jiang, Lorena Lerner, Jenő Gyuris, Zhigang Weng	2010	123
6	STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the α2-macroglobulin gene Genes & Development ·Lorena Lerner, Melissa A. Henriksen, Xiaokui Zhang, James Darnell	2003	90
7	Independent and Cooperative Activation of Chromosomal c-fos Promoter by STAT3 Journal of Biological Chemistry ·Edward Yang, Lorena Lerner, Daniel Besser, J E Darnell	2003	74
8	ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity Cancer Immunology Research ·Brian B. Haines, Agnieszka Denslow, Peter Grzesik, Jennifer S. Lee, Terry Farkaly, Jacqueline Hewett, Daniel Wambua, Lingxin Kong, Prajna Behera, Judith Jacques, Caitlin Goshert, Michael Ball, Allison Colthart, Mitchel H. Finer, Melissa Hayes, Sonia Feau, Edward M. Kennedy, Lorena Lerner, Christophe Quéva	2020	54
9	Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss Oncology Letters ·Lorena Lerner, Jenő Gyuris, Richard Nicoletti, James Gifford, Brian Krieger, Aminah Jatoi	2016	45
10	Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD European Respiratory Journal ·Gunnar Reksten Husebø, Rune Grønseth, Lorena Lerner, Jenő Gyuris, Jon A. Hardie, Per Bakke, Tomas Eagan	2017	43
11	Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort Cardiorenal Medicine ·Amy S. You, Kamyar Kalantar‐Zadeh, Lorena Lerner, Tracy Nakata, Nancy López, Lidia Lou, Mary Veliz, Melissa Soohoo, Jennie Jing, Frank Zaldivar, Jenő Gyuris, Danh V. Nguyen, Connie M. Rhee	2017	31
12	Risk factors for lung cancer in COPD – results from the Bergen COPD cohort study Respiratory Medicine ·Gunnar Reksten Husebø, Rune Nielsen, Jon A. Hardie, Per Bakke, Lorena Lerner, Corina N. D’Alessandro‐Gabazza, Jenő Gyuris, Esteban C. Gabazza, Pål Aukrust, Tomas Eagan	2019	23
13	Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability Molecular Therapy — Oncolytics ·Edward M. Kennedy, Terry Farkaly, Peter Grzesik, Jennifer S. Lee, Agnieszka Denslow, Jacqueline Hewett, Jeffrey D. Bryant, Prajna Behara, Caitlin Goshert, Daniel Wambua, Ana De Almeida, Judith Jacques, Damian G. Deavall, James B. Rottman, Joseph C. Glorioso, Mitchell Finer, Brian B. Haines, Christophe Quéva, Lorena Lerner	2020	20
14	Abstract 1455: Design of ONCR-177 base vector, a next generation oncolytic herpes simplex virus type-1, optimized for robust oncolysis, transgene expression and tumor-selective replication Cancer Research ·Edward M. Kennedy, Terry Farkaly, Prajna Behera, Allison Colthart, Caitlin Goshert, Judy Jacques, Kyle Grant, Peter Grzesik, Jennifer Lerr, Laura Viggiano Salta, Lorenz R. B. Ponce, Caroline Web, Brian B. Haines, Agnieszka Denslow, Jacqueline Gursha, Mitchell Finer, Christophe Quéva, Lorena Lerner	2019	5
15	Abstract 1153: Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody Cancer Research ·Lorena Lerner, Nianjun Tao, Brian Krieger, Richard Nicoletti, Bin Feng, Nesreen S. Ismail, William M. Winston, Yanyu Zhang, Jinwei Jiang, Solly Weiler, Jenő Gyuris	2015	4
16	A Recombinant Antibody Against ALK2 Promotes Tissue Iron Redistribution and Contributes to Anemia Resolution in a Mouse Model of Anemia of Inflammation American Journal of Hematology ·Chia‐Yu Wang, Emiliano Melgar‐Bermudez, Diana Welch, Kevin B. Dagbay, Seemana Bhattacharya, Evan Lema, Tyler Daman, O. Mateo-Sierra, Radina Todorova, Papa Makhtar Drame, Rosa Grenha, Ffolliott M. Fisher, Dena Grayson, Lorena Lerner, Samuel M. Cadena, Jasbir Seehra, Jennifer Lachey	2025	3
17	Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia. Cancer Research ·Antonio Viganò, Lorena Lerner, Nianjun Tao, Brian Krieger, Bin Feng, Richard Nicoletti, Qing Liu, Ailin Bai, Zhigang Weng, Thierry Alcindor, Domenico Fuoco, Jenő Gyuris, M. Isabel Chiu	2013	3
18	Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression Molecular Therapy — Oncolytics ·Jeffrey D. Bryant, Jennifer S. Lee, Ana De Almeida, Judy Jacques, Ching-Hung Chang, William Fassler, Christophe Quéva, Lorena Lerner, Edward M. Kennedy	2023	2
19	P992: A MODIFIED ACTIVIN RECEPTOR TYPE II LIGAND TRAP RKER-050 RESTORED ERYTHROPOIESIS IN A MOUSE MODEL OF MYELOFIBROSIS HemaSphere ·Blake S. Moses, Ashlyn Wheeler, Mike Dills, Samuel M. Cadena, Lorena Lerner, Jasbir Seehra, Jenn Lachey	2023	2
20	Abstract 1455: Design of ONCR-177 base vector, a next generation oncolytic herpes simplex virus type-1, optimized for robust oncolysis, transgene expression and tumor-selective replication Immunology ·Edward M. Kennedy, Terry Farkaly, Prajna Behera, Allison Colthart, Caitlin Goshert, Judy Jacques, Kyle Grant, Peter Grzesik, Jennifer Lerr, Laura Viggiano Salta, Lorenz R. B. Ponce, Caroline Web, B. M. Haines, Agnieszka Denslow, Jacqueline Gursha, Mitchell Finer, Christophe Quéva, Lorena Lerner	2019	1

About Lorena Lerner

Lorena Lerner is a scholar working on Molecular Biology, Rheumatology, Genetics, Immunology and Oncology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include GDF15 and Related Biomarkers (7 papers), Virus-based gene therapy research (6 papers), Nutrition and Health in Aging (5 papers), Viral gastroenteritis research and epidemiology (3 papers), RNA Interference and Gene Delivery (3 papers), Kruppel-like factors research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Rheumatology (315 citations), Physiology (353 citations), Small Animals (80 citations), Immunology (212 citations) and Oncology (262 citations). Lorena Lerner has collaborated with scholars based in United States, Norway and Switzerland. Frequent co-authors include Jenő Gyuris, M. Isabel Chiu, Richard Nicoletti, Brian Krieger, Nianjun Tao, H. Werchau, H. Hilpert, C Mietens, J Sidoti and Bin Feng. Their work appears in journals such as Cancer Research, Molecular Therapy — Oncolytics, Journal of Cachexia Sarcopenia and Muscle, Molecular Cancer Therapeutics and Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact